Eswatini vs Gambia: Population requiring preventive chemotherapy for schistosomiasis
Eswatini
411,702
in 2024
Gambia
657,160
in 2024
Eswatini rank
40th
Gambia rank
37th
Population requiring preventive chemotherapy for schistosomiasis over time
- Eswatini
- Gambia
How they compare
Gambia currently reports 657,160 against 411,702 in Eswatini, a difference of 245,458.
That makes Gambia's figure about 1.6 times Eswatini's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was Eswatini ahead.
Eswatini ranks 40th and Gambia ranks 37th of 52 countries.
Across the 2 decades both report, Eswatini averaged higher in 1 and Gambia in 1.
Head to head by decade
| Decade | Eswatini | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 304,182 | 158,622 | 145,560 | Eswatini |
| 2020s | 340,355 | 439,450 | 99,095 | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Eswatini or Gambia?
- Gambia, at 657,160 against 411,702 in Eswatini as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Eswatini and Gambia?
- 245,458, with Gambia ahead.
- How many years of comparable data are there for Eswatini and Gambia?
- 15 years are reported by both, from 2010 to 2024.
- How do Eswatini and Gambia rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Eswatini ranks 40th and Gambia ranks 37th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.